Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AVANTAX, INC.BCOR · Entity 107910 | Director · President and CEO | January 02, 2020 | January 06, 2020 |
| SCHWAB CHARLES CORPSCHW · Entity 1218 | EVP - Investor Services | November 03, 2014 | November 05, 2014 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AVANTAX, INC.
Report date January 02, 2020 · Filed January 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 634,297 |
Last balance in matching sequence
After 2020-01-03 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2020-01-02 · Tax withholding · Disposed 6,054 · Balance 637,413 F1: This transaction represents the withholding by the Issuer of shares to pay taxes in connection with the vesting of restricted stock units. The timing and amount of the transaction were determined by the terms of the applicable restricted stock unit award and were not within the control of the Reporting Person. F2: Not included in this amount are 119,132 performance-based restricted stock units of which (i) 12,906 are eligible to vest following May 6, 2020, (ii) 43,750 are eligible to vest from 0% to 200% following the end of 2020 and (iii) 62,476 are eligible to vest from 0% to 200% following the end of 2021. Vesting, for each award, is subject to the Issuer's achievement of certain financial goals over a three-year period and certification by the Compensation Committee. Row 2 · 2020-01-03 · Tax withholding · Disposed 3,116 · Balance 634,297 F1: This transaction represents the withholding by the Issuer of shares to pay taxes in connection with the vesting of restricted stock units. The timing and amount of the transaction were determined by the terms of the applicable restricted stock unit award and were not within the control of the Reporting Person. F2: Not included in this amount are 119,132 performance-based restricted stock units of which (i) 12,906 are eligible to vest following May 6, 2020, (ii) 43,750 are eligible to vest from 0% to 200% following the end of 2020 and (iii) 62,476 are eligible to vest from 0% to 200% following the end of 2021. Vesting, for each award, is subject to the Issuer's achievement of certain financial goals over a three-year period and certification by the Compensation Committee. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction represents the withholding by the Issuer of shares to pay taxes in connection with the vesting of restricted stock units. The timing and amount of the transaction were determined by the terms of the applicable restricted stock unit award and were not within the control of the Reporting Person.
F2: Not included in this amount are 119,132 performance-based restricted stock units of which (i) 12,906 are eligible to vest following May 6, 2020, (ii) 43,750 are eligible to vest from 0% to 200% following the end of 2020 and (iii) 62,476 are eligible to vest from 0% to 200% following the end of 2021. Vesting, for each award, is subject to the Issuer's achievement of certain financial goals over a three-year period and certification by the Compensation Committee.
SCHWAB CHARLES CORP
Report date November 03, 2014 · Filed November 05, 2014
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectby Trust | 76,197 |
Reported balance
After 2014-11-03 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2014-11-03 · Exercise / conversion · Acquired 6,332 · Balance 76,197 F1: Shares acquired on the vesting of restricted stock units. |
| Nonqualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.44 · Expires 2024-11-03 | Direct | 31,173 |
Reported balance
After 2014-11-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2014-11-03 · Grant · Acquired 31,173 · Balance 31,173 F2: The option was granted under the company's 2013 Stock Incentive Plan and vests in four equal annual installments beginning on the first anniversary of the grant date. |
| Common StockSEC Table I · non-derivative | Direct | 275 |
Reported balance
Holding disclosure · report date 2014-11-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 275 |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired on the vesting of restricted stock units.
F2: The option was granted under the company's 2013 Stock Incentive Plan and vests in four equal annual installments beginning on the first anniversary of the grant date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SVB FINANCIAL GROUP
Report date April 21, 2022 · Filed April 25, 2022
Section 16 reporting ended · disclosed 2022-04-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,735 |
Reported balance
After 2022-04-21 transaction · row 1
1 source rowRow 1 · 2022-04-21 · Exercise / conversion · Acquired 284 · Balance 2,735 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common Stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2031-05-03 | Direct | 0 |
Reported balance
After 2022-04-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-04-21 · Exercise / conversion · Disposed 284 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 21, 2022 Filed Apr 25, 2022 11:58 UTC | SVB FINANCIAL GROUP SIVB · Entity 86203 | Exercise / conversionRestricted Stock Unit · Derivative | 284 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-003522 · primarydocument.xml · derivative · entry 2 Clendening John S · CIK 0001388961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 284 shares Expires 2031-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common Stock. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 11:58 UTC | SVB FINANCIAL GROUP SIVB · Entity 86203 | Exercise / conversionCommon Stock | 284 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-003522 · primarydocument.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common Stock. Read SEC document |
| May 03, 2021 Filed May 5, 2021 11:44 UTC | SVB FINANCIAL GROUP SIVB · Entity 86203 | GrantRestricted Stock Unit · Derivative | 284 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-003184 · primarydocument.xml · derivative · entry 2 Clendening John S · CIK 0001388961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284 Underlying: Common Stock · 284 shares Expires 2031-05-03 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common Stock. F2 · shares: This transaction represents the reporting person's annual Director Equity grant of Restricted Stock Units. This award was granted on May 3, 2021, and is scheduled to vest upon the completion of the reporting person's 2021-2022 director term, currently expected to be on April 21, 2022 (the scheduled date of the Issuer's 2022 Annual Shareholder Meeting). Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 14:42 UTC | SVB FINANCIAL GROUP SIVB · Entity 86203 | Exercise / conversionRestricted Stock Unit · Derivative | 722 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-002937 · primarydocument.xml · derivative · entry 2 Clendening John S · CIK 0001388961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 722 shares Expires 2030-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common Stock. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 14:42 UTC | SVB FINANCIAL GROUP SIVB · Entity 86203 | Exercise / conversionCommon Stock | 722 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-002937 · primarydocument.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common Stock. Read SEC document |
| May 01, 2020 Filed May 5, 2020 09:42 UTC | SVB FINANCIAL GROUP SIVB · Entity 86203 | GrantRestricted Stock Unit · Derivative | 722 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003316 · primarydocument.xml · derivative · entry 2 Clendening John S · CIK 0001388961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 722 Underlying: Common Stock · 722 shares Expires 2030-05-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common Stock. F2 · shares: This transaction represents the reporting person's annual Director Equity grant of Restricted Stock Units. This award was granted on May 1, 2020, and is scheduled to vest upon the completion of the reporting person's 2020-2021 director term, currently expected to be on April 22, 2021 (the scheduled date of the Issuer's 2021 Annual Shareholder Meeting). Read SEC document |
| January 03, 2020 Filed Jan 6, 2020 17:21 UTC | AVANTAX, INC. BCOR · Entity 107910 | Tax withholdingCommon Stock | 3,116 | $25.73 | $80,174.68 |
DisclosureSEC source: 0001068875-20-000013 · wf-form4_157834926629273.xml · nonDerivative · entry 2 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,297 F1 · shares: This transaction represents the withholding by the Issuer of shares to pay taxes in connection with the vesting of restricted stock units. The timing and amount of the transaction were determined by the terms of the applicable restricted stock unit award and were not within the control of the Reporting Person. F2 · balance_after: Not included in this amount are 119,132 performance-based restricted stock units of which (i) 12,906 are eligible to vest following May 6, 2020, (ii) 43,750 are eligible to vest from 0% to 200% following the end of 2020 and (iii) 62,476 are eligible to vest from 0% to 200% following the end of 2021. Vesting, for each award, is subject to the Issuer's achievement of certain financial goals over a three-year period and certification by the Compensation Committee. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 17:21 UTC | AVANTAX, INC. BCOR · Entity 107910 | Tax withholdingCommon Stock | 6,054 | $26.00 | $157,404.00 |
DisclosureSEC source: 0001068875-20-000013 · wf-form4_157834926629273.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 637,413 F1 · shares: This transaction represents the withholding by the Issuer of shares to pay taxes in connection with the vesting of restricted stock units. The timing and amount of the transaction were determined by the terms of the applicable restricted stock unit award and were not within the control of the Reporting Person. F2 · balance_after: Not included in this amount are 119,132 performance-based restricted stock units of which (i) 12,906 are eligible to vest following May 6, 2020, (ii) 43,750 are eligible to vest from 0% to 200% following the end of 2020 and (iii) 62,476 are eligible to vest from 0% to 200% following the end of 2021. Vesting, for each award, is subject to the Issuer's achievement of certain financial goals over a three-year period and certification by the Compensation Committee. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 17:47 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001068875-19-000125 · wf-form4_157670921418018.xml · derivative · entry 3 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,499 Underlying: Common Stock · 7,500 shares Expires 2023-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 15% of the total option vested on April 4, 2016. The remainder vested 33.33% on April 4, 2017, and approximately 16.67% vested at the end of each six-month period thereafter, such that the option was fully vested on April 4, 2019. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 17:47 UTC | AVANTAX, INC. BCOR · Entity 107910 | SaleCommon Stock | 14,250 | $24.92 | $355,110.00 |
DisclosureSEC source: 0001068875-19-000125 · wf-form4_157670921418018.xml · nonDerivative · entry 2 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,467 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.48 to $25.14. Upon request by the SEC staff, the issuer or any security holder of the issuer, the reporting person will provide the full information regarding the number of shares sold at each separate price. F1 · balance_after: Not included in this amount are 119,132 performance-based restricted stock units of which (i) 12,906 are eligible to vest following May 6, 2020, (ii) 43,750 are eligible to vest from 0% to 200% following the end of 2020 and (iii) 62,476 are eligible to vest from 0% to 200% following the end of 2021. Vesting is subject to the issuers achievement of certain financial goals and certification by the Compensation Committee. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 17:47 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionCommon Stock | 7,500 | $4.98 | $37,350.00 |
DisclosureSEC source: 0001068875-19-000125 · wf-form4_157670921418018.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 657,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Not included in this amount are 119,132 performance-based restricted stock units of which (i) 12,906 are eligible to vest following May 6, 2020, (ii) 43,750 are eligible to vest from 0% to 200% following the end of 2020 and (iii) 62,476 are eligible to vest from 0% to 200% following the end of 2021. Vesting is subject to the issuers achievement of certain financial goals and certification by the Compensation Committee. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 17:04 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001068875-19-000093 · wf-form4_157065504096873.xml · derivative · entry 3 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,999 Underlying: Common Stock · 37,500 shares Expires 2023-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 15% of the total option vested on April 4, 2016. The remainder vested 33.33% on April 4, 2017 and approximately 16.67% vested at the end of each six month period thereafter, such that the option was fully vested on April 4, 2019. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 17:04 UTC | AVANTAX, INC. BCOR · Entity 107910 | SaleCommon Stock | 54,250 | $21.20 | $1,150,100.00 |
DisclosureSEC source: 0001068875-19-000093 · wf-form4_157065504096873.xml · nonDerivative · entry 2 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,217 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares sold in multiple transactions at prices ranging from $21.04 to $21.41. Upon request by the SEC staff, the issuer or any security holder of the issuer, the reporting person will provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: Not included in this amount are 119,132 performance-based restricted stock units of which (i) 12,906 are eligible to vest following May 6, 2020, (ii) 43,750 are eligible to vest from 0% to 200% following the end of 2020 and (iii) 62,476 are eligible to vest from 0% to 200% following the end of 2021. Vesting for each award is subject to the issuers achievement of certain financial goals and certification by the Compensation Committee. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 17:04 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionCommon Stock | 37,500 | $4.98 | $186,750.00 |
DisclosureSEC source: 0001068875-19-000093 · wf-form4_157065504096873.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 704,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2019 Filed Jul 18, 2019 17:06 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001068875-19-000077 · wf-form4_156348397703262.xml · derivative · entry 6 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,499 Underlying: Common Stock · 10,000 shares Expires 2023-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 15% of the total option vested on April 4, 2016. The remainder vested 33.33% on April 4, 2017, and approximately 16.67% vested at the end of each six-month period thereafter, such that the option was be fully vested on April 4, 2019. Read SEC document |
| July 17, 2019 Filed Jul 18, 2019 17:06 UTC | AVANTAX, INC. BCOR · Entity 107910 | SaleCommon Stock | 10,000 | $29.23 | $292,300.00 |
DisclosureSEC source: 0001068875-19-000077 · wf-form4_156348397703262.xml · nonDerivative · entry 4 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,967 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares sold in multiple transactions at prices ranging from $28.98 to $29.40. Upon request by the SEC staff, the issuer or any security holder of the issuer, the reporting person will provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| July 17, 2019 Filed Jul 18, 2019 17:06 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionCommon Stock | 10,000 | $4.98 | $49,800.00 |
DisclosureSEC source: 0001068875-19-000077 · wf-form4_156348397703262.xml · nonDerivative · entry 3 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 676,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 17:06 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001068875-19-000077 · wf-form4_156348397703262.xml · derivative · entry 5 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,499 Underlying: Common Stock · 37,500 shares Expires 2023-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 15% of the total option vested on April 4, 2016. The remainder vested 33.33% on April 4, 2017, and approximately 16.67% vested at the end of each six-month period thereafter, such that the option was be fully vested on April 4, 2019. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 17:06 UTC | AVANTAX, INC. BCOR · Entity 107910 | SaleCommon Stock | 54,250 | $29.01 | $1,573,792.50 |
DisclosureSEC source: 0001068875-19-000077 · wf-form4_156348397703262.xml · nonDerivative · entry 2 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,967 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.74 to $29.18. Upon request by the SEC staff, the issuer or any security holder of the issuer, the reporting person will provide the full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 17:06 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionCommon Stock | 37,500 | $4.98 | $186,750.00 |
DisclosureSEC source: 0001068875-19-000077 · wf-form4_156348397703262.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 721,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2019 Filed Jul 5, 2019 17:41 UTC | AVANTAX, INC. BCOR · Entity 107910 | Tax withholdingCommon Stock | 5,035 | $29.81 | $150,093.35 |
DisclosureSEC source: 0001068875-19-000075 · wf-form4_156236284731733.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683,717 F1 · shares: This transaction represents the withholding by the Issuer of shares to pay taxes in connection with the vesting of restricted stock units. The timing and amount of the transaction were determined by the terms of the applicable restricted stock unit award and were not within the control of the Reporting Person. Read SEC document |
| May 24, 2019 Filed May 29, 2019 13:10 UTC | SVB FINANCIAL GROUP SIVB · Entity 86203 | PurchaseCommon Stock | 900 | $221.12 | $199,006.56 |
DisclosureSEC source: 0001562180-19-003158 · primarydocument.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,729 Read SEC document |
| May 16, 2019 Filed May 16, 2019 17:45 UTC | AVANTAX, INC. BCOR · Entity 107910 | SaleCommon Stock | 5,000 | $32.00 | $160,000.00 |
DisclosureSEC source: 0001388961-19-000007 · wf-form4_155804311189954.xml · nonDerivative · entry 5 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688,752 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018. Read SEC document |
| May 15, 2019 Filed May 16, 2019 17:45 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001388961-19-000007 · wf-form4_155804311189954.xml · derivative · entry 7 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,999 Underlying: Common Stock · 20,000 shares Expires 2023-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 15% of the total option vested on April 4, 2016. The remainder vested 33.33% on April 4, 2017, and approximately 16.67% vested at the end of each six-month period thereafter, such that the option was fully vested on April 4, 2019. Read SEC document |
| May 15, 2019 Filed May 16, 2019 17:45 UTC | AVANTAX, INC. BCOR · Entity 107910 | SaleCommon Stock | 25,000 | $31.29 | $782,250.00 |
DisclosureSEC source: 0001388961-19-000007 · wf-form4_155804311189954.xml · nonDerivative · entry 4 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 693,752 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares sold in multiple transactions at prices ranging from $30.98 to $31.50. Upon request by the SEC staff, the issuer or any security holder of the issuer, the reporting person will provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2019 Filed May 16, 2019 17:45 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionCommon Stock | 20,000 | $4.98 | $99,600.00 |
DisclosureSEC source: 0001388961-19-000007 · wf-form4_155804311189954.xml · nonDerivative · entry 3 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 718,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2019 Filed May 16, 2019 17:45 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001388961-19-000007 · wf-form4_155804311189954.xml · derivative · entry 6 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,999 Underlying: Common Stock · 37,500 shares Expires 2023-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 15% of the total option vested on April 4, 2016. The remainder vested 33.33% on April 4, 2017, and approximately 16.67% vested at the end of each six-month period thereafter, such that the option was fully vested on April 4, 2019. Read SEC document |
| May 14, 2019 Filed May 16, 2019 17:45 UTC | AVANTAX, INC. BCOR · Entity 107910 | SaleCommon Stock | 54,250 | $31.67 | $1,718,097.50 |
DisclosureSEC source: 0001388961-19-000007 · wf-form4_155804311189954.xml · nonDerivative · entry 2 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 698,752 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares sold in multiple transactions at prices ranging from $31.03 to $31.90. Upon request by the SEC staff, the issuer or any security holder of the issuer, the reporting person will provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 14, 2019 Filed May 16, 2019 17:45 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionCommon Stock | 37,500 | $4.98 | $186,750.00 |
DisclosureSEC source: 0001388961-19-000007 · wf-form4_155804311189954.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 753,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2019 Filed May 3, 2019 13:17 UTC | SVB FINANCIAL GROUP SIVB · Entity 86203 | GrantRestricted Stock Unit · Derivative | 514 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001562180-19-002513 · primarydocument.xml · derivative · entry 2 Clendening John S · CIK 0001388961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514 Underlying: Common Stock · 514 shares Expires 2029-05-01 F1 · shares: This transaction represents the reporting person's annual Director Equity grant of Restricted Stock Units. This award was granted on May 1, 2019, and is scheduled to vest upon the completion of the reporting person's 2019-2020 director term, currently expected to be on April 23, 2020 (the scheduled date of the Issuer's 2020 Annual Shareholder Meeting). F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common Stock. Read SEC document |
| April 25, 2019 Filed Apr 29, 2019 16:26 UTC | SVB FINANCIAL GROUP SIVB · Entity 86203 | Exercise / conversionRestricted Stock Unit · Derivative | 492 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001562180-19-002414 · primarydocument.xml · derivative · entry 2 Clendening John S · CIK 0001388961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 492 shares Expires 2028-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common Stock. Read SEC document |
| April 25, 2019 Filed Apr 29, 2019 16:26 UTC | SVB FINANCIAL GROUP SIVB · Entity 86203 | Exercise / conversionCommon Stock | 492 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-19-002414 · primarydocument.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common Stock. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 07:47 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionStock Option (Right to Buy) · Derivative | 141,667 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001388961-19-000006 · wf-form4_155489680741132.xml · derivative · entry 3 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,499 Underlying: Common Stock · 141,667 shares Expires 2023-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 15% of the total option vested on April 4, 2016. The remainder vested 33.33% on April 4, 2017, and approximately 16.67% vested at the end of each six-month period thereafter, such that the option was fully vested on April 4, 2019. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 07:47 UTC | AVANTAX, INC. BCOR · Entity 107910 | Tax withholdingCommon Stock | 68,149 | $34.50 | $2,351,140.50 |
DisclosureSEC source: 0001388961-19-000006 · wf-form4_155489680741132.xml · nonDerivative · entry 2 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 715,502 F1 · shares: Represents a "net exercise" of outstanding stock options. The reporting person received 73,518 shares of common stock on net exercise of option to purchase 141,667 shares of common stock. The reporting person forfeited to the registrant 68,149 shares of common stock underlying the option in payment of the exercise price and applicable tax withholding, using the closing stock price on April 8, 2019 of $34.50. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 07:47 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionCommon Stock | 141,667 | $4.98 | $705,501.66 |
DisclosureSEC source: 0001388961-19-000006 · wf-form4_155489680741132.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 783,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents a "net exercise" of outstanding stock options. The reporting person received 73,518 shares of common stock on net exercise of option to purchase 141,667 shares of common stock. The reporting person forfeited to the registrant 68,149 shares of common stock underlying the option in payment of the exercise price and applicable tax withholding, using the closing stock price on April 8, 2019 of $34.50. Read SEC document |
| April 04, 2019 Filed Apr 5, 2019 16:18 UTC | AVANTAX, INC. BCOR · Entity 107910 | Tax withholdingCommon Stock | 27,873 | $34.70 | $967,193.10 |
DisclosureSEC source: 0001388961-19-000005 · wf-form4_155449552402843.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 641,984 F1 · shares: This transaction represents the withholding by the Issuer of shares to pay taxes in connection with the vesting of restricted stock units. The timing and amount of the transaction were determined by the terms of the applicable restricted stock unit award and were not within the control of the Reporting Person. Read SEC document |
| February 20, 2019 Filed Feb 21, 2019 18:04 UTC | AVANTAX, INC. BCOR · Entity 107910 | Tax withholdingCommon Stock | 11,476 | $27.48 | $315,360.48 |
DisclosureSEC source: 0001388961-19-000004 · wf-form4_155079026701761.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 669,857 F1 · shares: This transaction represents the withholding by the Issuer of shares to pay taxes in connection with the vesting of restricted stock units. The timing and amount of the transaction were determined by the terms of the applicable restricted stock unit award and were not within the control of the Reporting Person. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 16:21 UTC | AVANTAX, INC. BCOR · Entity 107910 | Tax withholdingCommon Stock | 3,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001388961-19-000002 · wf-form4_154663684985029.xml · nonDerivative · entry 2 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 681,333 F3 · shares: This transaction represents the withholding by the Issuer of shares to pay taxes in connection with the vesting of restricted stock units. The timing and amount of the transaction were determined by the terms of the applicable restricted stock unit award and were not within the control of the Reporting Person. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 16:21 UTC | AVANTAX, INC. BCOR · Entity 107910 | GrantStock Option (Right to Buy) · Derivative | 138,341 | $0.00 Strike: $27.03 | $0.00 |
DisclosureSEC source: 0001388961-19-000002 · wf-form4_154663684985029.xml · derivative · entry 3 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,341 Underlying: Common Stock · 138,341 shares Expires 2026-01-02 F4 · derivative.exercise_date: The option vests according to the following schedule: one-third vests on January 2, 2020, an additional one-third vest on January 2, 2021, and the remaining one-third will vest on January 2, 2022, such that the option will be fully vested on January 2, 2022. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 16:21 UTC | AVANTAX, INC. BCOR · Entity 107910 | GrantCommon Stock | 71,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001388961-19-000002 · wf-form4_154663684985029.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684,701 F1 · shares: Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on January 2, 2019 and that will vest equally over a three-year period on each anniversary of the grant date. F2 · balance_after: Not included in this amount are 62,476 performance-based restricted stock units, of which from 0% to 200% are eligible to vest following the end of the 2021 fiscal year subject to the Issuer's achievement of certain financial goals over a three-year period and certification by the Compensation Committee. Read SEC document |
| October 12, 2018 Filed Oct 15, 2018 16:40 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001388961-18-000016 · wf-form4_153963600812832.xml · derivative · entry 7 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,166 Underlying: Common Stock · 12,000 shares Expires 2023-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 15% of the total option vested on April 4, 2016. The remainder vested 33.33% on April 4, 2017, and approximately 16.67% vests at the end of each six-month period thereafter, such that the option will be fully vested on April 4, 2019. Read SEC document |
| October 12, 2018 Filed Oct 15, 2018 16:40 UTC | AVANTAX, INC. BCOR · Entity 107910 | SaleCommon Stock | 16,500 | $33.02 | $544,808.55 |
DisclosureSEC source: 0001388961-18-000016 · wf-form4_153963600812832.xml · nonDerivative · entry 5 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,299 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares sold in multiple transactions at prices ranging from $32.46 to $33.31. Upon request by the SEC staff, the issuer or any security holder of the issuer, the reporting person will provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| October 12, 2018 Filed Oct 15, 2018 16:40 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionCommon Stock | 12,000 | $4.98 | $59,760.00 |
DisclosureSEC source: 0001388961-18-000016 · wf-form4_153963600812832.xml · nonDerivative · entry 4 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 629,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 16:40 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionStock Option (Right to Buy) · Derivative | 34,000 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001388961-18-000016 · wf-form4_153963600812832.xml · derivative · entry 6 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,166 Underlying: Common Stock · 34,000 shares Expires 2023-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 15% of the total option vested on April 4, 2016. The remainder vested 33.33% on April 4, 2017, and approximately 16.67% vests at the end of each six-month period thereafter, such that the option will be fully vested on April 4, 2019. Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 16:40 UTC | AVANTAX, INC. BCOR · Entity 107910 | SaleCommon Stock | 17,797 | $33.66 | $598,974.05 |
DisclosureSEC source: 0001388961-18-000016 · wf-form4_153963600812832.xml · nonDerivative · entry 3 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617,799 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares sold in multiple transactions at prices ranging from $33.36 to $34.17. Upon request by the SEC staff, the issuer or any security holder of the issuer, the reporting person will provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 16:40 UTC | AVANTAX, INC. BCOR · Entity 107910 | SaleCommon Stock | 31,203 | $32.79 | $1,023,083.96 |
DisclosureSEC source: 0001388961-18-000016 · wf-form4_153963600812832.xml · nonDerivative · entry 2 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,596 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares sold in multiple transactions at prices ranging from $32.36 to $33.35. Upon request by the SEC staff, the issuer or any security holder of the issuer, the reporting person will provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 16:40 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionCommon Stock | 34,000 | $4.98 | $169,320.00 |
DisclosureSEC source: 0001388961-18-000016 · wf-form4_153963600812832.xml · nonDerivative · entry 1 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 16:41 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $14.75 | $0.00 |
DisclosureSEC source: 0001388961-18-000014 · wf-form4_153877206025304.xml · derivative · entry 7 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,372 Underlying: Common Stock · 50,000 shares Expires 2024-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 33.33% of the total option vested on January 3, 2018, and approximately 16.67% vests at the end of each six month period thereafter, such that the option will be fully vested on January 3, 2020. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 16:41 UTC | AVANTAX, INC. BCOR · Entity 107910 | Exercise / conversionStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001388961-18-000014 · wf-form4_153877206025304.xml · derivative · entry 6 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,166 Underlying: Common Stock · 55,000 shares Expires 2023-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 15% of the total option vested on April 4, 2016. The remainder vested 33.33% on April 4, 2017, and approximately 16.67% vests at the end of each six-month period thereafter, such that the option will be fully vested on April 4, 2019. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 16:41 UTC | AVANTAX, INC. BCOR · Entity 107910 | Tax withholdingCommon Stock | 27,872 | $37.06 | $1,032,936.32 |
DisclosureSEC source: 0001388961-18-000014 · wf-form4_153877206025304.xml · nonDerivative · entry 5 Clendening John S · CIK 0001388961 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 632,799 F3 · shares: This transaction represents the withholding by the Issuer of shares to pay taxes in connection with the vesting of restricted stock units. The timing and amount of the transaction were determined by the terms of the applicable restricted stock unit award and were not within the control of the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.